台北地方法院駁回向心夫婦返港申請
中國創新投資(01217.HK)及中國趨勢(08171.HK)主席向心及其妻子龔青,以有需要回港處理公司業務及就醫為由,對台北地檢署的出境限制提出上訴,遭台北地方法院駁回。
台北地方法院判決時表示,以現今通訊科技發達情況,向心在台灣境內未遭限制通訊、行動自由,處理公司業務可以透過影音通訊或委由他人代理;又指二人出入境台灣逾20次,並在台灣接受過醫學美容及購置多筆不動產,認為二人熟悉台灣生活及醫療環境,因此駁回申請。
向心夫婦於去年11月底被台灣當局依違反《國安法》發展組織罪調查,並被限制出境。二人先後兩度委託律師,向台北地檢署提出解除出境限制呈請均被否決。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.